Article
Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).
Human mutation - 1 Oct 2009
Hwu Wuh-Liang, Chien Yin-Hsiu, Lee Ni-Chung, Chiang Shu-Chuan, Dobrovolny Robert, Huang Ai-Chu, Yeh Hui-Ying, Chao May-Chin, Lin Shio-Jean, Kitagawa Teruo, Desnick Robert J, Hsu Li-Wen
Abstract excerpt
Fabry disease (alpha-galactosidase A (alpha-Gal A, GLA) deficiency) is a panethnic inborn error of glycosphingolipid metabolism. Because optimal therapeutic outcomes depend on early intervention, a pilot program was designed to assess newborn screening for this disease in 171,977 consecutive Taiwanese newborns by measuring their dry blood spot (DBS) alpha-Gal A activities and beta-galactosidase/alpha-Gal A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
